References
- Alles MJRC, der Gaag MA, Stokroos RJ. (2006). Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol 263:1–20. doi: 10.1007/s00405-006-0065-3.
- Augusthy AR, Chandran S, K.V V. (2017). Design and evaluation of an in situ forming implant system of an anti-inflammatory drug. Indo Am J Pharm Sci 4:983–94.
- Bird PA, Murray DP, Zhang M, Begg EJ. (2011). Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol 32:933–6. doi: 10.1097/MAO.0b013e3182255933.
- Breglio AM, Rusheen AE, Shide ED, et al. (2017). Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun 8:1654. doi: 10.1038/s41467-017-01837-1.
- Brownell WE. (1997). How the ear works - natures’s solution for listening. Volta Rev 99:9–28.
- Bruschi ML. (2015). Mathematical models of drug release. In: Strategies to modify the drug release from pharmaceutical systems. Sawston, CA: Woodhead Publishing.
- Cai J, Wu X, Li X, et al. (2019). Allicin protects against cisplatin-induced stria vascularis damage: possible relation to inhibition of caspase-3 and PARP-1-AIF-mediated apoptotic pathways. ORL J Otorhinolaryngol Relat Spec 81:202–14. doi: 10.1159/000500557.
- Cardin V. (2016). Effects of aging and adult-onset hearing loss on cortical auditory regions. Front Neurosci 10:199. doi: 10.3389/fnins.2016.00199.
- Casiraghi A, Gennari CG, Musazzi UM, et al. (2020). Mucoadhesive budesonide formulation for the treatment of eosinophilic esophagitis. Pharmaceutics 12:211. doi: 10.3390/pharmaceutics12090822.
- Chen Y, Cheng G, Hu R, et al. (2019). A nasal temperature and pH dual-responsive in situ gel delivery system based on microemulsion of huperzine A: formulation, evaluation, and in vivo pharmacokinetic study. AAPS PharmSciTech 20:301. doi: 10.1208/s12249-019-1513-x.
- Chiappisi L, Noirez L, Gradzielski M. (2016). A journey through the phase diagram of a pharmaceutically relevant microemulsion system. J Colloid Interface Sci 473:52–9. doi: 10.1016/j.jcis.2016.03.064.
- Choi M-J, Kang H, Lee YY, et al. (2019). Cisplatin-induced ototoxicity in rats is driven by RIP3-dependent necroptosis. Cells 8:409. doi: 10.3390/cells8050409.
- Cohen BE, Durstenfeld A, Roehm PC. (2014). Viral causes of hearing loss: A review for hearing health professionals. Trends Hear 18:233121651454136.
- Curtis LM, ten Cate WJ, Rarey KE. (1993). Dynamics of Na,K-ATPase sites in lateral cochlear wall tissues of the rat. Eur Arch Otorhinolaryngol 250:265–70. doi: 10.1007/BF00186223.
- Dahm V, Nieratschker M, Riss D, et al. (2019). Intratympanic tiamcinolone acetonide as treatment option for idiopathic sudden sensorineural hearing loss. Otol Neurotol 40:720–7. doi: 10.1097/MAO.0000000000002283.
- Dindelegan MG, Blebea C, Perde-Schrepler M, et al. (2022). Recent advances and future research directions for hearing loss treatment based on nanoparticles. J Nanomater 2022:1–15. doi: 10.1155/2022/7794384.
- Doktorovova S, Souto EB, Silva AM. (2014). Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers – a systematic review of in vitro data. Eur J Pharm Biopharm 87:1–18. doi: 10.1016/j.ejpb.2014.02.005.
- Duan M, Zhi-Qiang C. (2009). Permeability of round window membrane and its role for drug delivery: our own findings and literature review. J Otol 4:34–43. doi: 10.1016/S1672-2930(09)50006-2.
- Duran Alonso MB, Lopez Hernandez I, de la Fuente MA, et al. (2018). Transcription factor induced conversion of human fibroblasts towards the hair cell lineage. PLoS One 13:e0200210. doi: 10.1371/journal.pone.0200210.
- Engleder E, Honeder C, Klobasa J, et al. (2014). Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear. Int J Pharm 471:297–302. doi: 10.1016/j.ijpharm.2014.05.057.
- Fakhari A, Corcoran M, Schwarz A. (2017). Thermogelling properties of purified poloxamer 407. Heliyon 3:e00390. doi: 10.1016/j.heliyon.2017.e00390.
- Fernandez K, Wafa T, Fitzgerald TS, Cunningham LL. (2019). An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity. Hear Res 375:66–74. doi: 10.1016/j.heares.2019.02.006.
- Fettiplace R. (2017). Hair cell transduction, tuning, and synaptic transmission in the mammalian cochlea. Compr Physiol 7:1197–227. doi: 10.1002/cphy.c160049.
- Freitas LM, Antunes FTT, Obach ES, et al. (2021). Anti-inflammatory effects of a topical emulsion containing Helianthus annuus oil, glycerin, and vitamin B3 in mice. J Pharm Investig 51:223–32. doi: 10.1007/s40005-020-00508-6.
- Gacek RR. (2021). On the nature of hearing loss in Méniere’s disease. ORL J Otorhinolaryngol Relat Spec 83:144–50. doi: 10.1159/000511113.
- Gausterer JC, Saidov N, Ahmadi N, et al. (2020). Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear. Eur J Pharm Biopharm 150:143–55. doi: 10.1016/j.ejpb.2020.03.005.
- Giuliano E, Paolino D, Fresta M, Cosco D. (2018). Mucosal applications of poloxamer 407-based hydrogels: an overview. Pharmaceutics 10:159. doi: 10.3390/pharmaceutics10030159.
- Gong C, Qi T, Wei X, et al. (2012). Thermosensitive polymeric hydrogels as drug delivery systems. CMC 20:79–94. doi: 10.2174/0929867311302010009.
- Guo X, Bai X, Li L, et al. (2018). Forskolin protects against cisplatin-induced ototoxicity by inhibiting apoptosis and ROS production. Biomed Pharmacother 99:530–6. doi: 10.1016/j.biopha.2018.01.080.
- Guzman J, Ruiz J, Eshraghi AA, et al. (2006). Triamcinolone acetonide protects auditory hair cells from 4-hydroxy-2,3-nonenal (HNE) ototoxicity in vitro. Acta Otolaryngol 126:685–90. doi: 10.1080/00016480500492018.
- Hajjar B, Zier K-I, Khalid N, et al. (2018). Evaluation of a microemulsion-based gel formulation for topical drug delivery of diclofenac sodium. J Pharm Investig 48:351–62. doi: 10.1007/s40005-017-0327-7.
- Hasan N, Cao J, Lee J, et al. (2021). Development of clindamycin-loaded alginate/pectin/hyaluronic acid composite hydrogel film for the treatment of MRSA-infected wounds. J Pharm Investig 51:597–610. doi: 10.1007/s40005-021-00541-z.
- Hodge SE, Lopez IA, Ishiyama G, Ishiyama A. (2021). Cisplatin ototoxicity histopathology. Laryngoscope Investig Otolaryngol 6:852–6. doi: 10.1002/lio2.608.
- Honeder C, Engleder E, Schöpper H, et al. (2014). Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses. Audiol Neurootol 19:193–202. doi: 10.1159/000358165.
- Honeder C, Zhu C, Schöpper H, et al. (2016). Effects of sustained release dexamethasone hydrogels in hearing preservation cochlear implantation. Hear Res 341:43–9. doi: 10.1016/j.heares.2016.08.001.
- Hosny KM, Hassan AH. (2014). Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation. Int J Pharm 475:191–7. doi: 10.1016/j.ijpharm.2014.08.064.
- Jain S, Patel N, Lin S. (2015). Solubility and dissolution enhancement strategies: current understanding and recent trends. Drug Dev Ind Pharm 41:875–87. doi: 10.3109/03639045.2014.971027.
- Jumaily M, Faraji F, Mikulec AA. (2017). Intratympanic triamcinolone and dexamethasone in the treatment of Ménière’s syndrome. Otol Neurotol 38:386–91. doi: 10.1097/MAO.0000000000001311.
- Kim DH, Nguyen TN, Han YM, et al. (2021). Local drug delivery using poly(lactic-coglycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment. Drug Deliv 28:2268–77. doi: 10.1080/10717544.2021.1992041.
- Kim SH, Kim SR, Yoon HY, et al. (2017). Poloxamer 407 hydrogels for intravesical instillation to mouse bladder: gel-forming capacity and retention performance. Korean J Urol Oncol 15:178–86. doi: 10.22465/kjuo.2017.15.3.178.
- Kuduban O, Kucur C, Sener E, et al. (2013). The Role of thiamine pyrophosphate in prevention of cisplatin ototoxicity in an animal model. Sci World J 2013:1–5. doi: 10.1155/2013/182694.
- Kurabi A, Keithley EM, Housley GD, et al. (2017). Cellular mechanisms of noise-induced hearing loss. Hear Res 349:129–37. doi: 10.1016/j.heares.2016.11.013.
- Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 45:89–121. doi: 10.1016/s0169-409x(00)00103-4.
- Lin TJ, Kurihara H, Ohta H. (1977). Prediction of optimum o/w emulsification via solubilization measurements. J Soc Cosmet Chem Japan 11:32–42. doi: 10.5107/sccj1976.11.2_32.
- Mehta DP, Rathod HJ, Shah DP, Shah CN. (2015). A review on microemulsion based gel: a recent approach for topical drug delivery system. *** 8:118. doi: 10.5958/0974-360X.2015.00021.9.
- Morales D, Gutiérrez JM, García-Celma MJ, Solans YC. (2003). A Study of the relation between bicontinuous microemulsions and oil/water nano-emulsion formation. Langmuir 19:7196–200. doi: 10.1021/la0300737.
- Moreau D, Lefort C, Burke R, et al. (2015). Rhodamine B as an optical thermometer in cells focally exposed to infrared laser light or nanosecond pulsed electric fields. Biomed Opt Express 6:4105–17. doi: 10.1364/BOE.6.004105.
- Nguyen TN, Park JS. (2023). Intratympanic drug delivery systems to treat inner ear impairments. J Pharm Investig 53:93–118. doi: 10.1007/s40005-022-00586-8.
- Nyberg S, Abbott NJ, Shi X, et al. (2019). Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier. Sci Transl Med 11:eaao0935. doi: 10.1126/scitranslmed.aao0935.
- Patra M, Salonen E, Terama E, et al. (2006). Under the influence of alcohol: the effect of ethanol and methanol on lipid bilayers. Biophys J 90:1121–35. doi: 10.1529/biophysj.105.062364.
- Piu F, Wang X, Fernandez R, et al. (2011). OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otol Neurotol 32:171–9. doi: 10.1097/MAO.0b013e3182009d29.
- Plontke SK, Mikulec AA, Salt AN. (2008). Rapid clearance of methylprednisolone after intratympanic application in humans versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 29:732–3; author reply 733. doi: 10.1097/MAO.0b013e318173fcea.
- Pyykkö I, Zou J, Zhang W, Zhang Y. (2011). Nanoparticle-based delivery for the treatment of inner ear disorders. Curr Opin Otolaryngol Head Neck Surg 19:388–96. doi: 10.1097/MOO.0b013e32834aa3a8.
- Rauch SD, Halpin CF, Antonelli PJ, et al. (2011). Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearingloss. JAMA 305:2071–9. doi: 10.1001/jama.2011.679.
- Richter CA, Amin S, Linden J, et al. (2010). Defects in middle ear cavitation cause conductive hearing loss in the Tcof1 mutant mouse. Hum Mol Genet 19:1551–60. doi: 10.1093/hmg/ddq028.
- Rizk HG, Lee JA, Liu YF, et al. (2020). Drug-induced ototoxicity: a comprehensive review and reference guide. Pharmacotherapy 40:1265–75. doi: 10.1002/phar.2478.
- Ross MD, Ernst SA, Kerr TP. (1982). Possible functional roles of Na+, K+-ATPase in the inner ear and their relevance to Ménière’s disease. Am J Otolaryngol 3:353–60. doi: 10.1016/s0196-0709(82)80010-0.
- Russo E, Villa C. (2019). Poloxamer hydrogels for biomedical applications. Pharmaceutics 11:671. doi: 10.3390/pharmaceutics11120671.
- Sabale V, Vora S. (2012). Formulation and evaluation of microemulsion-based hydrogel for topical delivery. Int J Pharm Investig 2:140–9. doi: 10.4103/2230-973X.104397.
- Shah B. (2021). Microemulsion as a promising carrier for nose to brain delivery: journey since last decade. J Pharm Investig 51:611–34. doi: 10.1007/s40005-021-00528-w.
- Salt AN, Plontke SK. (2018). Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications. Hear Res 368:28–40. doi: 10.1016/j.heares.2018.03.002.
- Schacht J, Talaska AE, Rybak LP. (2012). Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec (Hoboken) 295:1837–50. doi: 10.1002/ar.22578.
- Schindler RA, Gladstone HB, Scott N, et al. (1995). Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors. The American Journal of Otology 16:304–9. http://www.ncbi.nlm.nih.gov/pubmed/8588623
- Scomoroscenco C, Teodorescu M, Raducan A, et al. (2021). Novel gel microemulsion as topical drug delivery system for curcumin in dermatocosmetics. Pharmaceutics 13:505. doi: 10.3390/pharmaceutics13040505.
- Shafiq-Un-Nabi S, Shakeel F, Talegaonkar S, et al. (2007). Formulation development and optimization using nanoemulsion technique: A technical note. AAPS PharmSciTech 8:Article 28. doi: 10.1208/pt0802028.
- Shukla T, Upmanyu N, Agrawal M, et al. (2018). Biomedical applications of microemulsion through dermal and transdermal route. Biomed Pharmacother 108:1477–94. doi: 10.1016/j.biopha.2018.10.021.
- Silverstein H, Choo D, Rosenberg SI, et al. (1996). Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 75:468–71, 474, 476 passim. passim. doi: 10.1177/014556139607500806.
- Sohmer H. (1997). Pathophysiological mechanisms of hearing loss. J Basic Clin Physiol Pharmacol 8:113–25. doi: 10.1515/jbcpp.1997.8.3.113.
- Szeto B, Chiang H, Valentini C, et al. (2020). Inner ear delivery: Challenges and opportunities. Laryngoscope Investig Otolaryngol 5:122–31. doi: 10.1002/lio2.336.
- Takeda T, Takeda S, Kakigi A. (2020). Effects of glucocorticoids on the inner ear. Front Surg 7:596383. doi: 10.3389/fsurg.2020.596383.
- Talegaonkar S, Azeem A, Ahmad F, et al. (2008). Microemulsions: a novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul 2:238–57. doi: 10.2174/187221108786241679.
- Tenjarla S. (1999). Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carr Syst 16:461–521.
- Thakkar PJ, Madan P, Lin S. (2014). Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation. Pharm Dev Technol 19:373–84. doi: 10.3109/10837450.2013.788658.
- Trune DR, Canlon B. (2012). Corticosteroid therapy for hearing and balance disorders. Anat Rec (Hoboken) 295:1928–43. doi: 10.1002/ar.22576.
- van Ruijven MWM, de Groot JCMJ, Klis SFL, Smoorenburg GF. (2005). The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 205:241–8. doi: 10.1016/j.heares.2005.03.023.
- Vigata M, Meinert C, Hutmacher DW, Bock N. (2020). Hydrogels as drug delivery systems: a review of current characterization and evaluation techniques. Pharmaceutics 12:1188. doi: 10.3390/pharmaceutics12121188.
- Vona B, Haaf T. (Eds.). (2016). Genetics of Deafness (Vol. 20). Basel: S. Karger AG.
- Wang L-L, Huang S, Guo H, et al. (2016). In situ delivery of thermosensitive gel-mediated 5-fluorouracil microemulsion for the treatment of colorectal cancer. Drug Des Devel Ther 10:2855–67. doi: 10.2147/DDDT.S111351.
- Wang X, Dellamary L, Fernandez R, et al. (2009). Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol Neurootol 14:393–401. doi: 10.1159/000241896.
- Wang X, Dellamary L, Fernandez R, et al. (2011a). Principles of inner ear sustained release following intratympanic administration. Laryngoscope 121:385–91. doi: 10.1002/lary.21370.
- Wang Z, Sugano E, Isago H, et al. (2011b). Differentiation of neuronal cells from NIH/3T3 fibroblasts under defined conditions. Dev Growth Differ 53:357–65. doi: 10.1111/j.1440-169X.2010.01235.x.
- Wissel K, Brandes G, Pütz N, et al. (2018). Platinum corrosion products from electrode contacts of human cochlear implants induce cell death in cell culture models. Plos ONE 13:e0196649. doi: 10.1371/journal.pone.0196649.
- Yang CJ, Chung JW. (2016). Pathophysiology of noise induced hearing loss. Audiol Speech Res 12:S14–S16. doi: 10.21848/asr.2016.12.S1.S14.
- Yu X, Man R, Li Y, et al. (2019). Paeoniflorin protects spiral ganglion neurons from cisplatin-induced ototoxicity: Possible relation to PINK1/BAD pathway. J Cell Mol Med 23:5098–107. doi: 10.1111/jcmm.14379.
- Zhang L, Chen S, Sun Y. (2021). Mechanism and prevention of spiral ganglion neuron degeneration in the cochlea. Front Cell Neurosci 15:814891. doi: 10.3389/fncel.2021.814891.
- Zhou Q, Tripathi P. (2012). How to remake a fibroblast into a neural stem cell. Cell Stem Cell 10:347–8. doi: 10.1016/j.stem.2012.03.005.
- Zimmer WM, Rosin DF, Saunders JC. (1994). Middle-ear development VI: Structural maturation of the rat conducting apparatus. Anat Rec 239:475–84. doi: 10.1002/ar.1092390413.